Paul Elson

18.3k total citations · 3 hit papers
334 papers, 13.4k citations indexed

About

Paul Elson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Paul Elson has authored 334 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Pulmonary and Respiratory Medicine, 128 papers in Oncology and 78 papers in Molecular Biology. Recurrent topics in Paul Elson's work include Renal cell carcinoma treatment (98 papers), Cancer Genomics and Diagnostics (53 papers) and Renal and related cancers (40 papers). Paul Elson is often cited by papers focused on Renal cell carcinoma treatment (98 papers), Cancer Genomics and Diagnostics (53 papers) and Renal and related cancers (40 papers). Paul Elson collaborates with scholars based in United States, India and United Kingdom. Paul Elson's co-authors include Ronald M. Bukowski, Brian I. Rini, Laura S. Wood, Robert Dreicer, Tarek Mekhail, Patrick J. Loehrer, Jorge A. García, Ali Golshayan, Victor W. Fazio and Bartholomäus Böhm and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Paul Elson

325 papers receiving 13.1k citations

Hit Papers

A randomized comparison o... 1992 2026 2003 2014 1992 2009 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    1992 752 citations Paul Elson et al. Journal of Clinical Oncology profile →
  2. Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
    2009 690 citations Jennifer S. Ko, Arnold H. Zea et al. Clinical Cancer Research profile →
  3. A Prospective, Randomized Trial Comparing Laparoscopic Versus Conventional Techniques in Colorectal Cancer Surgery: A Preliminary Report
    1998 525 citations Paul Elson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul Elson 5.6k 4.7k 4.5k 3.2k 2.6k 334 13.4k
Marianna Zahurak 5.0k 0.9× 6.8k 1.4× 3.5k 0.8× 5.7k 1.8× 2.1k 0.8× 221 16.8k
Allan T. van Oosterom 10.1k 1.8× 9.3k 2.0× 4.5k 1.0× 4.3k 1.3× 2.8k 1.1× 89 21.9k
Emilio Bajetta 5.8k 1.0× 10.4k 2.2× 3.9k 0.9× 1.9k 0.6× 3.7k 1.4× 325 16.6k
Patrick Schöffski 9.5k 1.7× 9.6k 2.0× 4.8k 1.1× 3.2k 1.0× 2.2k 0.9× 510 19.4k
Ezra E.W. Cohen 5.6k 1.0× 8.5k 1.8× 4.7k 1.0× 3.2k 1.0× 2.0k 0.8× 421 16.9k
Manisha H. Shah 3.3k 0.6× 7.7k 1.6× 4.3k 1.0× 2.4k 0.8× 2.1k 0.8× 203 18.0k
Isabelle Ray‐Coquard 5.5k 1.0× 7.0k 1.5× 2.8k 0.6× 3.6k 1.1× 1.8k 0.7× 418 16.7k
Geoffrey R. Weiss 4.6k 0.8× 8.2k 1.7× 4.2k 0.9× 1.5k 0.5× 1.5k 0.6× 194 13.1k
Janice P. Dutcher 5.8k 1.0× 6.5k 1.4× 6.5k 1.4× 1.2k 0.4× 3.0k 1.2× 272 14.7k
Joel Picus 9.2k 1.6× 9.3k 2.0× 4.2k 1.0× 2.5k 0.8× 4.6k 1.8× 224 18.1k

Countries citing papers authored by Paul Elson

Since Specialization
Citations

This map shows the geographic impact of Paul Elson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Elson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Elson more than expected).

Fields of papers citing papers by Paul Elson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Elson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Elson. The network helps show where Paul Elson may publish in the future.

Co-authorship network of co-authors of Paul Elson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Elson. A scholar is included among the top collaborators of Paul Elson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Elson. Paul Elson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harel, Ran, Todd Emch, Paul Elson, et al.. (2022). A quantitative and comparative evaluation of stereotactic spine radiosurgery local control: proposing a consistent measurement methodology. Neurosurgical FOCUS. 53(5). E10–E10.
2.
Elson, Paul, et al.. (2017). Areas of Medico-Legal Unreliability in Personal Injury Cases. 2(1). 1–3. 2 indexed citations
3.
Rahman, Shafia, Dana E. Angelini, Paul Elson, et al.. (2017). Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience. Blood. 130. 4633–4633. 3 indexed citations
4.
Ahmed, Hina, Sagar S. Patel, Bhumika Patel, et al.. (2017). Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies. Blood. 130. 532–532. 1 indexed citations
5.
6.
Sidana, Surbhi, Sudipto Mukherjee, Paul Elson, et al.. (2013). The Degree and Effect Of Weight Loss In Acute Myeloid Leukemia Patients Receiving Induction and Post-Remission Chemotherapy. Blood. 122(21). 3889–3889. 3 indexed citations
7.
Manola, Judith, Patrick Royston, Paul Elson, et al.. (2011). Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group. Clinical Cancer Research. 17(16). 5443–5450. 148 indexed citations
8.
9.
Samplaski, Mary K., Warren D.W. Heston, Paul Elson, Cristina Magi‐Galluzzi, & Donna E. Hansel. (2011). Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Modern Pathology. 24(11). 1521–1529. 50 indexed citations
10.
Borden, Ernest C., Barbara Jacobs, Lisa Rybicki, et al.. (2011). Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial. Journal of Interferon & Cytokine Research. 31(5). 433–440. 25 indexed citations
11.
Ching, Christina B., Mohammed A. Amin, Raymond R. Tubbs, et al.. (2011). HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Modern Pathology. 24(8). 1111–1119. 83 indexed citations
12.
Shaik, Mohammed, Yuka Sugimoto, Michael J. Clemente, et al.. (2010). Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia. Blood. 116(21). 2236–2236. 2 indexed citations
13.
Ko, Jennifer S., Arnold H. Zea, Brian I. Rini, et al.. (2009). Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients. Clinical Cancer Research. 15(6). 2148–2157. 690 indexed citations breakdown →
14.
Sekeres, Mikkael A., Paul Elson, Matt Kalaycio, et al.. (2008). Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood. 113(1). 28–36. 146 indexed citations
15.
Choueiri, Toni K., A. Plantade, Paul Elson, et al.. (2007). Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma. Journal of Clinical Oncology. 26(1). 127–131. 311 indexed citations
16.
Thakkar, Snehal G., David M. Peereboom, Thomas Olencki, et al.. (2006). Short Communication: Phase I Clinical and Gene Modulatory Evaluation of Tamoxifen and IFN- α 2b. Journal of Interferon & Cytokine Research. 26(11). 800–803. 2 indexed citations
17.
Hercbergs, Aleck, James Mason, C.A. Reddy, & Paul Elson. (2004). Thyroid hormones and lung cancer: Primary hypothyroidism is prognostically significant for survival in lung cancer. Cancer Research. 64. 1024–1024. 5 indexed citations
18.
Vaziri, S. A., Lisa M. Krumroy, Paul Elson, et al.. (2001). Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.. PubMed. 7(7). 1937–45. 51 indexed citations
19.
Jones, Monica, Thierry Philip, Peter Palmer, et al.. (1993). The Impact of Interleukin-2 on Survival in Renal Cancer: A Multivariate Analysis. PubMed. 8(4). 275–288. 61 indexed citations
20.
Trump, D L, Paul Elson, Ernest C. Borden, et al.. (1987). High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study.. PubMed. 71(2). 165–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Zahurak Breakdown of academic impact, for papers by Allan T. van Oosterom Breakdown of academic impact, for papers by Emilio Bajetta Breakdown of academic impact, for papers by Patrick Schöffski Breakdown of academic impact, for papers by Ezra E.W. Cohen Breakdown of academic impact, for papers by Manisha H. Shah Breakdown of academic impact, for papers by Isabelle Ray‐Coquard Breakdown of academic impact, for papers by Geoffrey R. Weiss Breakdown of academic impact, for papers by Janice P. Dutcher Breakdown of academic impact, for papers by Joel Picus
Rankless by CCL
2026